As KB said yesterday the future of PLS and the industry is not with sales of spodumene. It will be more about our mid stream product or similar products. I have heard other CEO's acknowledge the need to watch developments in this space.
It would seem that, to remain relevant, other companies may need to either spend a lot of time (years) and money to develop a similar product or use PLS/Calixĺ technology.
Using PLS technology will come at a cost. The company have said they would be agreeable and consideration of 5% of that companies sales, from this use, for the first 10 years would be the fee. If I remember correctly.
That could amount to a lot of income if prices remain at or near current levels and several took up the offer.
This is another reason I and others here cheer each and every announcement regarding our progress with Calix. That is my understanding of what is going down but you better DYOR.
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-13409
-
- There are more pages in this discussion • 33,264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.28 |
Change
0.120(3.80%) |
Mkt cap ! $9.907B |
Open | High | Low | Value | Volume |
$3.22 | $3.30 | $3.21 | $66.30M | 20.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 288502 | $3.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.29 | 308089 | 43 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 239267 | 3.250 |
24 | 262248 | 3.240 |
27 | 236535 | 3.230 |
34 | 290327 | 3.220 |
15 | 339910 | 3.210 |
Price($) | Vol. | No. |
---|---|---|
3.260 | 198052 | 39 |
3.270 | 154668 | 20 |
3.280 | 344356 | 25 |
3.290 | 338180 | 20 |
3.300 | 264600 | 37 |
Last trade - 15.36pm 30/09/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |